Ivermectin: An Effective Remedy Against Various Diseases: A Literature Review

Message:
Article Type:
Review Article (دارای رتبه معتبر)
Abstract:
Introduction

Ivermectin is a member of avermectins family which was discovered in 1967 in Japan. The contribution of this drug to animal and human health was so prominent that the researchers who found the drug were awarded a Noble prize in 2015. With the advent of COVID-19,lot of interest has shifted more towards ivermectin usage in treating the COVID-19 alone or in combination with other medicines as synergism. Since its introduction, ivermectin has helped to control many parasitic diseases of animals and humans. For many years after its discovery, ivermectin was considered to be only a parasitic agent, but as scientists continue to evaluate this drug, they discover more healing aspects.

Materials and Methods

For this review, we searched keywords from international databases including PubMed, Google Scholar, Science Direct and Scopus. The keywords were ivermectin, anticancer, anti-inflammation, antibacterial, antivirus, antiparasitic, and mechanism of action.

Results

Several studies have shown that ivermectin has a very powerful antiparasitic, antibacterial, and antiviral activity and it can also be used as an anticancer and anti-inflammatory agent.

Conclusion

The collected data showed that ivermectin can be used to control and prevent many pathogenic agents and it can also be repurposed for the treatment of COVID-19.

Language:
English
Published:
Archives of Advances in Biosciences, Volume:13 Issue: 1, Winter 2022
Page:
15
https://magiran.com/p2460316  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!